Oruka Therapeutics, Inc.
ORKA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000907654
In the last 90 days, Oruka Therapeutics, Inc. insiders filed 0 open-market purchases and 16 sales; 255 institutions reported holding it in 13F filings for Q2 2026, worth $7.05B in total; Viking Global Investors is the only superinvestor holding it.
13F holders, Q1 2022
Institutional positions in Oruka Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- +1 vs. Q4 2021
- Shares held
- 1.13M
- +12.3K (+1.1%) vs. Q4 2021
- Total value
- $2.60M
- +$196.0K (+8.1%) vs. Q4 2021
- New holders
- 5
- 5 more added
- Sold out
- 4
- 6 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ORKA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 255 | $7.05B |
| Q1 2026 | 184 | $2.55B |
| Q4 2025 | 143 | $1.60B |
| Q3 2025 | 105 | $875.8M |
| Q2 2025 | 81 | $386.0M |
| Q1 2025 | 71 | $326.1M |
| Q4 2024 | 66 | $606.6M |
| Q3 2024 | 42 | $604.2M |
| Q2 2024 | 32 | $49.4M |
| Q1 2024 | 23 | $12.7M |
| Q4 2023 | 25 | $12.7M |
| Q3 2023 | 21 | $6.55M |
| Q2 2023 | 23 | $5.75M |
| Q1 2023 | 26 | $5.02M |
| Q4 2022 | 22 | $6.19M |
| Q3 2022 | 25 | $4.58M |
| Q2 2022 | 24 | $4.17M |
| Q1 2022 | 22 | $2.60M |
| Q4 2021 | 21 | $2.41M |
| Q3 2021 | 19 | $4.53M |
| Q2 2021 | 17 | $4.16M |
| Q1 2021 | 17 | $3.20M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Oruka Therapeutics, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 459,562 | $1.06M | 0.00% | +53,279+13.1% | Added |
| BlackRock Inc. | 269,877 | $620.0K | 0.00% | −1,845−0.7% | Reduced |
| Geode Capital Management, LLC | 96,326 | $221.0K | 0.00% | +968+1.0% | Added |
| State Street Corp | 69,937 | $161.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 53,737 | $124.0K | 0.00% | +13,770+34.5% | Added |
| Dimensional Fund Advisors LP | 42,498 | $98.0K | 0.00% | 00.0% | Unchanged |
| Tekla Capital Management LLC | 32,461 | $75.0K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 23,874 | $55.0K | 0.00% | +23,874 | New |
| Bridgeway Capital Management, LLC | 21,948 | $50.0K | 0.00% | +21,948 | New |
| Northern Trust Corp | 17,517 | $40.0K | 0.00% | 00.0% | Unchanged |
| Marquette Asset Management, LLC | 17,318 | $40.0K | 0.01% | +17,318 | New |
| Millennium Management LLC | 11,424 | $26.0K | 0.00% | −17,024−59.8% | Reduced |
| UBS Group AG | 5,026 | $12.0K | 0.00% | −2,558−33.7% | Reduced |
| Tower Research Capital LLC (TRC) | 4,951 | $11.0K | 0.00% | +2,666+116.7% | Added |
| Simplex Trading, LLC | 2,604 | $5.00K | 0.00% | −12,581−82.9% | Reduced |
| Citigroup Inc | 1,790 | $4.00K | 0.00% | +1,790 | New |
| TD Waterhouse Canada Inc. | 1,300 | $2.86K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 675 | $2.00K | 0.00% | +675 | New |
| Parallel Advisors, LLC | 244 | $1.00K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 31 | $0 | 0.00% | −27−46.6% | Reduced |
| Wells Fargo & Company | 89 | $0 | 0.00% | +1+1.1% | Added |
| Advisor Group Holdings, Inc. | 57 | $0 | 0.00% | −50−46.7% | Reduced |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −57,822−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −32,067−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Tyler-Stone Wealth Management | 0 | $0 | 0.00% | −50−100.0% | Sold out |